🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
122,22 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
148,73 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 2 días
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
15/06/2026 0,8500 USD
16/03/2026 0,8500 USD
15/12/2025 0,8500 USD
15/09/2025 0,8100 USD
16/06/2025 0,8100 USD
17/03/2025 0,8100 USD
16/12/2024 0,8100 USD
16/09/2024 0,7700 USD
17/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7700 USD
14/09/2023 0,7300 USD
14/06/2023 0,7300 USD
14/03/2023 0,7300 USD
14/12/2022 0,7300 USD
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
15/09/2020 80,85 81,27 79,82 80,35 +0,06% 1,79% 10.826.678
14/09/2020 80,34 81,20 79,90 80,31 -0,38% 1,63% 8.575.994
11/09/2020 80,00 80,99 79,94 80,61 +1,09% 1,31% 7.171.254
10/09/2020 80,85 80,99 79,47 79,74 -1,54% 1,89% 6.907.578
09/09/2020 79,93 81,89 79,83 80,99 +1,86% 2,58% 8.862.307
08/09/2020 82,00 82,00 79,20 79,51 -2,24% 3,42% 9.095.592
04/09/2020 81,63 82,91 80,39 81,34 -0,29% 3,09% 9.359.688
03/09/2020 83,67 83,78 81,05 81,57 -1,66% 3,26% 12.983.672
02/09/2020 80,61 83,22 80,41 82,95 +2,96% 3,48% 11.571.597
01/09/2020 81,44 81,87 80,08 80,56 -0,99% 2,20% 6.797.433
31/08/2020 81,68 81,99 81,24 81,36 -0,44% 0,92% 7.929.273
28/08/2020 81,95 81,95 81,02 81,73 -0,20% 1,13% 6.134.049
27/08/2020 81,54 82,21 81,18 81,89 +0,33% 1,26% 6.464.902
26/08/2020 81,40 81,76 80,78 81,62 -0,16% 1,20% 7.844.175
25/08/2020 81,98 82,34 81,30 81,76 +0,30% 1,27% 10.245.982
24/08/2020 81,30 81,56 80,61 81,51 +0,52% 1,16% 7.582.280
21/08/2020 81,20 81,28 80,27 81,09 -0,06% 1,25% 6.890.495
20/08/2020 80,92 81,40 80,52 81,14 +0,00% 1,08% 6.380.434
19/08/2020 80,69 81,78 80,69 81,14 +0,56% 1,36% 6.896.050
18/08/2020 81,00 81,12 79,93 80,69 -0,24% 1,46% 6.551.572
17/08/2020 80,42 81,28 80,16 80,88 +1,53% 1,39% 8.764.319
14/08/2020 79,56 80,56 79,36 79,66 -0,07% 1,51% 7.390.496
13/08/2020 78,37 79,80 78,25 79,71 +1,04% 1,97% 7.455.262
12/08/2020 77,64 79,11 77,61 78,89 +2,19% 1,93% 7.295.652
11/08/2020 78,01 78,12 76,94 77,20 +0,00% 1,52% 7.636.671
10/08/2020 77,30 77,49 76,62 77,20 -0,14% 1,12% 5.782.445
07/08/2020 77,09 77,31 76,36 77,31 -0,04% 1,23% 6.977.584
06/08/2020 77,73 78,62 76,89 77,34 -0,72% 2,22% 7.256.562
05/08/2020 78,31 78,69 77,43 77,90 -0,04% 1,61% 6.492.465
04/08/2020 78,77 78,77 77,36 77,93 -1,05% 1,79% 7.218.729